Jacob Young, MD

Title(s)Assistant Professor, Neurological Surgery
SchoolSchool of Medicine
Address513 Parnassus Avenue, HSE, #815
San Francisco CA 94143
PronounsHe/Him/His
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse education and training
    Duke University, Durham, NCBS05/2012Neuroscience
    University of Chicago, Chicago, ILMD06/2017Medicine
    University of California, San Francisco, San Francisco, CAResidency06/2024Neurosurgery
    Collapse awards and honors
    American Society of Clinical Oncology (ASCO)2022  - 2023Young Investigator Award
    UCSF2020UCSF Exceptional Physician Award
    Chan-Zuckerberg Biohub, UCSF2021  - 2022Chan-Zuckerberg Physician Scientist Fellow
    San Francisco Neurosurgical Society2023Edwin Boldrey Award
    UCSF Department of Neurological Surgery2023Harold Rosegay Resident Teaching Award
    Western Neurosurgical Society2022Best Basic Science Abstract
    UCSF Department of Neurological Surgery2022Best Senior Resident Translational Paper Award
    American Association of Neurological Surgeons (AANS)2022National Brain Tumor Society Award
    American Association of Neurological Surgeons (AANS)2022Donald O. Quest Award
    Glioblastoma Foundation2021Neil Peart Neurosurgery Research Award
    American Association of Neurological Surgeons (AANS)2021Donald O. Quest Award
    San Francisco Neurosurgical Society2021Harold Rosegay Award
    UCSF Department of Neurological Surgery2019Howard Naffziger Award
    San Francisco Neurosurgical Society2020Harold Rosegay Award
    UCSF Department of Neurological Surgery2019Best Junior Research Paper Award
    San Francisco General Hospital, UCSF2018Krevans Award for Excellence in Patient Care
    University of Chicago Pritzker School of Medicine2017Alpha Omega Alpha Honor Society
    University of Chicago Pritzker School of Medicine2017Outstanding Achievement Award in Medicine
    University of Chicago Pritzker School of Medicine2017Graduation with Honors
    University of Chicago Pritzker School of Medicine2017Peter Huttenlocher & Douglas Buchanan Prize
    University of Chicago Pritzker School of Medicine2017Departmental Award for Outstanding Performance in Surgery
    Neurosurgery Research & Education Foundation (NREF)/American Association of Neurological Surgeons2015Medical Student Summer Research Fellowship
    University of Chicago Pritzker School of Medicine2014The Brain Research Foundation Award for Neuroscience
    Duke University2013Phi Beta Kappa
    Duke University2012Graduation with Distinction
    UCSF Department of Neurological Surgery2024Harold Rosegay Resident Teaching Award

    Collapse Overview 
    Collapse overview
    Dr. Jacob Young is a neurosurgeon who cares for patients with brain tumors, including low- and high-grade gliomas, meningiomas and brain metastases (cancer that has spread to the brain). He specializes in brain mapping techniques that identify areas important for motor, language and sensory functions, enabling surgeons to minimize the impact on these areas during surgery to remove a tumor. His clinical research explores how to optimize functional outcomes and minimize complications after surgery for intrinsic brain tumors.

    Dr. Young's translational research interests include first-in-human early-phase clinical trials of new immunotherapies and innovative ways to deliver drugs to treat cancerous brain tumors. In his lab, he focuses on understanding the microenvironment of glioma and how it contributes to intratumoral heterogeneity (differences between cancer cells within the same tumor), treatment resistance and cancer evolution at the time of progression. Working with numerous collaborators, his ultimate goal is to design treatment strategies that improve outcomes for patients with brain tumors. His glioblastoma research has been recognized at the institutional, regional, and national levels. During his postdoctoral training, he was awarded the Chan Zuckerberg Biohub Physician-Scientist fellowship, the Andrew J. Lockhart Focused Ultrasound and Immuno-Oncology fellowship, and the American Society of Clinical Oncology Young Investigator Award.

    Dr. Young earned his medical degree from the University of Chicago Pritzker School of Medicine, where he was elected to the Alpha Omega Alpha Honor Medical Society. He completed a residency in neurosurgery and a postdoctoral fellowship in tumor immunology at UCSF, where he received an Exceptional Physician Award during his training. He was recognized with the Krevan's Award for excellence in patient care at the Zuckerberg San Francisco General Hospital and the Howard Naffziger Award for Outstanding Clinical Service from the department of neurological surgery.

    Collapse Research 
    Collapse research activities and funding
    Development of a AI-guided Neuro-Oncology Patient Navigator (BrainGPT)
    Department of Energy NAIRR240060
    Role: PI

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: A report by the RANO resect group. Journal of Clinical Oncology. 2025 Jun 1; 43(16_suppl):2001-2001. Karschnia KP, Young YJ, Wijnenga WM, Wagner WA, Schnell SO, Häni HL, Esquenazi EY, Vik-Mo VE, Rudà RR, Vogelbaum VM, Hervey-Jumper HS, Beck BJ, Dietrich DJ, Grau GS, Park PY, Youssef YG, Jakola JA, Bello BL, Berger BM, Tonn TJ. .
      View in: Publisher Site   Mentions:
    2. The Role of Lobectomy in Glioblastoma Management: A Retrospective series. Brain and Spine. 2025 Jun 1; 104305. Arvaniti AC, Brotis BA, Young YJ, Sivanrupan SS, Menna MG, Nishide NM, Schucht SP, Berger BM, Fountas FK. .
      View in: Publisher Site   Mentions:
    3. Glioma-neuronal circuit remodeling induces regional immunosuppression. Nat Commun. 2025 May 22; 16(1):4770. Nejo T, Krishna S, Yamamichi A, Lakshmanachetty S, Jimenez C, Lee KY, Baker DL, Young JS, Chen T, Phyu SSS, Phung L, Gallus M, Maldonado GC, Okada K, Ogino H, Watchmaker PB, Diebold D, Choudhury A, Daniel AGS, Cadwell CR, Raleigh DR, Hervey-Jumper SL, Okada H. PMID: 40404658; PMCID: PMC12098748.
      View in: PubMed   Mentions:    Fields:    
    4. Current and Future Applications of 5-Aminolevulinic Acid in Neurosurgical Oncology. Cancers (Basel). 2025 Apr 15; 17(8). Chen JS, Young JS, Berger MS. PMID: 40282508; PMCID: PMC12025619.
      View in: PubMed   Mentions:
    5. 1330 The Impact of Systemic Disease Status on Postoperative Outcomes After Resection of Brain Metastases: A Single Center Study. Neurosurgery. 2025 Apr 1; 71(Supplement_1):221-222. Catalan CT, Lui LA, Young YJ, Theodosopoulos TP, Hervey-Jumper HS, Aghi AM, Morshed MR. .
      View in: Publisher Site   Mentions:
    6. 1337 The Impact of Brain Metastasis Multiplicity on Postoperative Survival and CNS Progression: A Single Center Study. Neurosurgery. 2025 Apr 1; 71(Supplement_1):224-224. Lui LA, Catalan CT, Young YJ, Theodosopoulos TP, Hervey-Jumper HS, Aghi AM, Morshed MR. .
      View in: Publisher Site   Mentions:
    7. IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma. bioRxiv. 2025 Mar 14. Young JS, Cho NW, Lucas CG, Najem H, Mirchia K, Chen WC, Seo K, Zakimi N, Daggubati V, Casey-Clyde T, Nguyen MP, Chen A, Phillips JJ, Ozawa T, Aghi MK, Taylor JW, DeRisi JL, Bhaduri A, Berger MS, Heimberger AB, Butowski N, Spitzer MH, Raleigh DR. PMID: 40161763; PMCID: PMC11952432.
      View in: PubMed   Mentions:
    8. Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival. Neurooncol Adv. 2025 Jan-Dec; 7(1):vdaf024. Rodriguez Almaraz E, Guerra GA, Al-Adli NN, Young JS, Dada A, Quintana D, Taylor JW, Oberheim Bush NA, Clarke JL, Butowski NA, de Groot J, Pekmezci M, Perry A, Bollen AW, Scheffler AW, Glidden DV, Phillips JJ, Costello JF, Chang EF, Hervey-Jumper S, Berger MS, Francis SS, Chang SM, Solomon DA. PMID: 40051658; PMCID: PMC11883348.
      View in: PubMed   Mentions:
    9. Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses. Neuro Oncol. 2025 Jan 12; 27(1):89-105. Lucas CG, Al-Adli NN, Young JS, Gupta R, Morshed RA, Wu J, Ravindranathan A, Shai A, Oberheim Bush NA, Taylor JW, de Groot J, Villanueva-Meyer JE, Pekmezci M, Perry A, Bollen AW, Theodosopoulos PV, Aghi MK, Chang EF, Hervey-Jumper SL, Raleigh DR, Molinaro AM, Costello JF, Diaz AA, Clarke JL, Butowski NA, Phillips JJ, Chang SM, Berger MS, Solomon DA. PMID: 39560080; PMCID: PMC11726253.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    10. Co-evolution of glioma and immune microenvironment. J Immunother Cancer. 2024 Dec 03; 12(12). Elguindy MM, Young JS, Ho WS, Lu RO. PMID: 39631850; PMCID: PMC11624716.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    11. SURG-24. MAXIMAL SAFE RESECTION OF INSULAR GLIOMAS: AN EVALUATION OF SURGICAL AND PROGNOSTIC OUTCOMES IN 461 CASES. Neuro-Oncology. 2024 Nov 11; 26(Supplement_8):viii279-viii279. Al-Adli AN, Young YJ, Li LJ, Quintana QD, Dada DA, Menna MG, Gerritsen GJ, Morshed MR, Hervey-Jumper HS, Berger BM. .
      View in: Publisher Site   Mentions:
    12. PATH-53. DNA MUTATION SEQUENCING AND METHYLATION ANALYSIS OF SOMATICNF1 MUTANT IDH-WILDTYPE GLIOBLASTOMA IDENTIFIES THREE EPIGENETIC GROUPS ANDCDKN2A/B LOSS AS A NEGATIVE PROGNOSTIC BIOMARKER. Neuro-Oncology. 2024 Nov 11; 26(Supplement_8):viii191-viii191. Mirchia MK, Pan PS, Payne PE, Liu LJ, Peeran PZ, Shukla SP, Young YJ, Gupta GR, Wu WJ, Pak PJ, Seo SK, Ozawa OT, Na NB, Reddy RA, Braunstein BS, Phillips PJ, Chang CS, Solomon SD, Perry PA, Raleigh RD, Berger BM, Abate AA, Vasudevan VH. .
      View in: Publisher Site   Mentions:
    13. PATH-08. MOLECULAR DIVERGENCE RATES DIFFER BETWEEN BRAIN METASTASES AND EXTRACRANIAL DISEASE SITES ACROSS PRIMARY TUMOR HISTOLOGIES. Neuro-Oncology. 2024 Nov 11; 26(Supplement_8):viii179-viii179. Morshed MR, Khela KH, Nguyen NM, Young YJ, Goldschmidt GE, McDermott MM, Malik MN, Parney PI, Chang CE, Berger BM, Theodosopoulos TP, Hervey-Jumper HS, Huppert HL, Aghi AM, Vasudevan VH. .
      View in: Publisher Site   Mentions:
    14. CNSC-52. OLIGODENDROGLIOMA SPATIAL TRANSCRIPTOMIC SEQUENCING REVEALS THERAPY-DEPENDENT EVOLUTION OVER TIME. Neuro-Oncology. 2024 Nov 11; 26(Supplement_8):viii52-viii53. Mirchia MK, Young YJ, Nguyen NM, Vasudevan VH, de Groot dJ, Raleigh RD. .
      View in: Publisher Site   Mentions:
    15. P18.54.B DEVELOPMENT AND VALIDATION OF A CLINICAL RISK SCORE FOR POSTOPERATIVE OUTCOME IN NEWLY DIAGNOSED GLIOBLASTOMA: A REPORT OF THE RANO RESECT GROUP. Neuro-Oncology. 2024 Oct 17; 26(Supplement_5):v110-v110. Karschnia KP, Young YJ, Youssef YG, Dono DA, Häni HL, Sciortino ST, Bruno BF, Juenger JS, Teske TN, Dietrich DJ, Weller WM, Vogelbaum VM, van den Bent vM, Beck BJ, Thon TN, Gerritsen GJ, Hervey-Jumper HS, Cahill CD, Chang CS, Rudà RR, Bello BL, Schnell SO, Esquenazi EY, Ruge RM, Grau GS, Huang HR, Wen WP, Berger BM, Molinaro MA, Tonn TJ. .
      View in: Publisher Site   Mentions:
    16. Reporting standards in randomized controlled trials involving neuro-oncology caregivers: A systematic review report from the RANO-Cares working group. Neuro-Oncology Practice. 2024 Sep 20; npae086. Boele BF, Hertler HC, Sherwood SP, Cachia CD, Dirven DL, Young YJ, Walbert WT, Stockdill SM, Almaraz AE, Piil PK. .
      View in: Publisher Site   Mentions:
    17. Resection versus biopsy in patients with glioblastoma (RESBIOP study): study protocol for an international multicentre prospective cohort study (ENCRAM 2202). BMJ Open. 2024 09 10; 14(9):e081689. Gerritsen JKW, Young JS, Krieg SM, Jungk C, Ille S, Schucht P, Nahed BV, Broekman MLD, Berger M, De Vleeschouwer S, Vincent AJPE. PMID: 39260848; PMCID: PMC11409263.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    18. Glioblastoma induces the recruitment and differentiation of dendritic-like "hybrid" neutrophils from skull bone marrow. Cancer Cell. 2024 Sep 09; 42(9):1549-1569.e16. Lad M, Beniwal AS, Jain S, Shukla P, Kalistratova V, Jung J, Shah SS, Yagnik G, Saha A, Sati A, Babikir H, Nguyen AT, Gill S, Rios J, Young JS, Lui A, Salha D, Diaz A, Aghi MK. PMID: 39255776; PMCID: PMC11446475.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    19. MerlinS13 phosphorylation regulates meningioma Wnt signaling and magnetic resonance imaging features. Nat Commun. 2024 Sep 09; 15(1):7873. Eaton CD, Avalos L, Liu SJ, Chen Z, Zakimi N, Casey-Clyde T, Bisignano P, Lucas CG, Stevenson E, Choudhury A, Vasudevan HN, Magill ST, Young JS, Krogan NJ, Villanueva-Meyer JE, Swaney DL, Raleigh DR. PMID: 39251601; PMCID: PMC11383945.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    20. Interventional neurorehabilitation for glioma patients: A systematic review. Neurooncol Pract. 2024 Dec; 11(6):679-690. Ekert JO, Goyal A, Young JS, Hervey-Jumper SL, Berger MS. PMID: 39554784; PMCID: PMC11567740.
      View in: PubMed   Mentions:
    21. Development and validation of a clinical risk score for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO Resect group. Journal of Clinical Oncology. 2024 Jun 1; 42(16_suppl):2060-2060. Karschnia KP, Young YJ, Dono DA, Häni HL, Jünger JS, Sciortino ST, Teske TN, Youssef YG, Bruno BF, Vogelbaum VM, Rudà RR, Huang HR, Wen WP, Bello BL, Grau GS, Schnell SO, Esquenazi EY, Chang CS, Berger BM, Tonn TJ. .
      View in: Publisher Site   Mentions:
    22. SUPRAMAX-study: supramaximal resection versus maximal resection for glioblastoma patients: study protocol for an international multicentre prospective cohort study (ENCRAM 2201). BMJ Open. 2024 04 29; 14(4):e082274. Gerritsen JKW, Young JS, Chang SM, Krieg SM, Jungk C, van den Bent MJ, Satoer DD, Ille S, Schucht P, Nahed BV, Broekman MLD, Berger M, De Vleeschouwer S, Vincent AJPE. PMID: 38684246; PMCID: PMC11086386.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    23. Strategies to Improve Drug Delivery Across the Blood-Brain Barrier for Glioblastoma. Curr Neurol Neurosci Rep. 2024 05; 24(5):123-139. Narsinh KH, Perez E, Haddad AF, Young JS, Savastano L, Villanueva-Meyer JE, Winkler E, de Groot J. PMID: 38578405; PMCID: PMC11016125.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    24. Targeted DNA Sequencing Reveals Molecular Factors Associated with Clinical Outcomes in Recurrent Glioblastoma. Neurosurgery. 2024 Apr 1; 70(Supplement_1):199-200. Al-Adli AN, Chen CW, Young YJ, Mirchia MK, Peeran PZ, Braunstein BS, Perry PA, de Groot dJ, Raleigh RD, Costello CJ, Berger BM, Vasudevan VH. .
      View in: Publisher Site   Mentions:
    25. Skull-Derived Myeloid Cells Augment T Cell Responses and Suppress Glioblastoma Growth. Neurosurgery. 2024 Apr 1; 70(Supplement_1):202-202. Lad LM, Young YJ, Salha SD, Lui LA, Aghi AM. .
      View in: Publisher Site   Mentions:
    26. 1236 Skull-Derived Myeloid Cells Augment T Cell Responses and Suppress Glioblastoma Growth. Neurosurgery. 2024 Apr 1; 70(Supplement_1):193-193. Lad LM, Young YJ, Lui LA, Salha SD, Aghi AM. .
      View in: Publisher Site   Mentions:
    27. Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO resect group. Neuro Oncol. 2024 03 04; 26(3):584-586. Karschnia P, Dono A, Young JS, Juenger ST, Teske N, Häni L, Sciortino T, Mau CY, Bruno F, Nunez L, Morshed RA, Haddad AF, Weller M, van den Bent M, Thon N, Beck J, Hervey-Jumper S, Molinaro AM, Tandon N, Rudà R, Vogelbaum MA, Bello L, Schnell O, Grau SJ, Chang SM, Berger MS, Esquenazi Y, Tonn JC. PMID: 38164632; PMCID: PMC10911992.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. The importance of considering competing risks in recurrence analysis of intracranial meningioma. J Neurooncol. 2024 Feb; 166(3):503-511. Mirian C, Jensen LR, Juratli TA, Maier AD, Torp SH, Shih HA, Morshed RA, Young JS, Magill ST, Bertero L, Stummer W, Spille DC, Brokinkel B, Oya S, Miyawaki S, Saito N, Proescholdt M, Kuroi Y, Gousias K, Simon M, Moliterno J, Prat-Acin R, Goutagny S, Prabhu VC, Tsiang JT, Wach J, Güresir E, Yamamoto J, Kim YZ, Lee JH, Koshy M, Perumal K, Baskaya MK, Cannon DM, Shrieve DC, Suh CO, Chang JH, Kamenova M, Straumann S, Soleman J, Eyüpoglu IY, Catalan T, Lui A, Theodosopoulos PV, McDermott MW, Wang F, Guo F, Góes P, de Paiva Neto MA, Jamshidi A, Komotar R, Ivan M, Luther E, Souhami L, Guiot MC, Csonka T, Endo T, Barrett OC, Jensen R, Gupta T, Patel AJ, Klisch TJ, Kim JW, Maiuri F, Barresi V, Tabernero MD, Skyrman S, Broechner A, Bach MJ, Law I, Scheie D, Kristensen BW, Munch TN, Meling T, Fugleholm K, Blanche P, Mathiesen T. PMID: 38336917; PMCID: PMC10876814.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Glioma-Immune Cell Crosstalk in Tumor Progression. Cancers (Basel). 2024 Jan 11; 16(2). Elguindy M, Young JS, Mondal I, Lu RO, Ho WS. PMID: 38254796; PMCID: PMC10813573.
      View in: PubMed   Mentions: 4  
    30. Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group. Neuro Oncol. 2024 01 05; 26(1):166-177. Karschnia P, Dietrich J, Bruno F, Dono A, Juenger ST, Teske N, Young JS, Sciortino T, Häni L, van den Bent M, Weller M, Vogelbaum MA, Morshed RA, Haddad AF, Molinaro AM, Tandon N, Beck J, Schnell O, Bello L, Hervey-Jumper S, Thon N, Grau SJ, Esquenazi Y, Rudà R, Chang SM, Berger MS, Cahill DP, Tonn JC. PMID: 37665776; PMCID: PMC10768992.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    31. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade. Acta Neuropathol. 2023 12 11; 147(1):3. Hadad S, Gupta R, Oberheim Bush NA, Taylor JW, Villanueva-Meyer JE, Young JS, Wu J, Ravindranathan A, Zhang Y, Warrier G, McCoy L, Shai A, Pekmezci M, Perry A, Bollen AW, Phillips JJ, Braunstein SE, Raleigh DR, Theodosopoulos P, Aghi MK, Chang EF, Hervey-Jumper SL, Costello JF, de Groot J, Butowski NA, Clarke JL, Chang SM, Berger MS, Molinaro AM, Solomon DA. PMID: 38079020; PMCID: PMC10713691.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    32. The surgical management of diffuse gliomas: Current state of neurosurgical management and future directions. Neuro Oncol. 2023 12 08; 25(12):2117-2133. Young JS, Morshed RA, Hervey-Jumper SL, Berger MS. PMID: 37499054; PMCID: PMC10708937.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    33. Advances in Intraoperative Glioma Tissue Sampling and Infiltration Assessment. Brain Sci. 2023 Nov 25; 13(12). Al-Adli NN, Young JS, Scotford K, Sibih YE, Payne J, Berger MS. PMID: 38137085; PMCID: PMC10741454.
      View in: PubMed   Mentions: 1  
    34. IMMU-04. LOW-INTENSITY PULSED ULTRASOUND ENHANCES CAR T CELL THERAPY BY INDUCING TWO-WAY IMMUNE CELL TRAFFICKING – T CELL INTO TUMOR AND MYELOID CELL INTO PERIPHERY IN A SYNGENEIC MOUSE GLIOBLASTOMA MODEL. Neuro-Oncology. 2023 Nov 10; 25(Supplement_5):v141-v142. Yamamichi YA, Chen CT, Phyu PS, Young YJ, Kyewarabye KK, Hatae HR, Gallus GM, Canney CM, Sonabend SA, Okada OH. .
      View in: Publisher Site   Mentions:
    35. TMIC-34. SKULL-DERIVED MYELOID CELLS AUGMENT T CELL RESPONSES AND SUPPRESS GLIOBLASTOMA GROWTH. Neuro-Oncology. 2023 Nov 10; 25(Supplement_5):v285-v285. Lad LM, Kalistratova KV, Young YJ, Gill GS, Saha SA, Rios RJ, Salha SD, Lui LA, Aghi AM. .
      View in: Publisher Site   Mentions:
    36. EXTH-34. LOCAL DELIVERY OF AN IL-15 SUPERAGONIST USING A REPLICATING RETROVIRUS SYNGERIZES WITH TEMOZOLOMIDE TO INCREASE LYMPHOCYTE INFILTRATION AND SURVIVAL IN TWO POORLY IMMUNOGENIC GLIOBLASTOMA MOUSE MODELS. Neuro-Oncology. 2023 Nov 10; 25(Supplement_5):v231-v231. Haddad HA, Spatz SJ, Saha SA, Montoya MM, Collins CS, Gill GS, Wang WE, Chuntova CP, Salha SD, Young YJ, Kasahara KN, Aghi AM. .
      View in: Publisher Site   Mentions:
    37. BIOM-31. TARGETED DNA SEQUENCING OF RECURRENT GLIOBLASTOMA IDENTIFIES MOLECULAR FACTORS ASSOCIATED WITH CLINICAL OUTCOMES. Neuro-Oncology. 2023 Nov 10; 25(Supplement_5):v11-v11. Al-Adli AN, Chen CW, Young YJ, Mirchia MK, Peeran PZ, Braunstein BS, Perry PA, de Groot dJ, Raleigh RD, Costello CJ, Berger BM, Vasudevan VH. .
      View in: Publisher Site   Mentions:
    38. CNSC-06. REDIRECTING IMMUNOSUPPRESSIVE GLIOMA MICROENVIRONMENT THROUGH PHARMACOLOGICAL INTERVENTION TARGETING NEURONAL ACTIVITY. Neuro-Oncology. 2023 Nov 10; 25(Supplement_5):v23-v23. Nejo NT, Krishna KS, Yamamichi YA, Jimenez JC, Lakshmanachetty LS, Young YJ, Phyu PS, Watchmaker WP, Hervey-Jumper HS, Okada OH. .
      View in: Publisher Site   Mentions:
    39. PATH-40. “DE NOVO REPLICATION REPAIR DEFICIENT GLIOBLASTOMA, IDH-WILDTYPE” IS A DISTINCT GLIOBLASTOMA SUBTYPE IN ADULTS THAT MAY BENEFIT FROM IMMUNE CHECKPOINT BLOCKADE. Neuro-Oncology. 2023 Nov 10; 25(Supplement_5):v177-v177. Hadad HS, Bush BN, Clarke CJ, Taylor TJ, Young YJ, Villanueva-Meyer VJ, Zhang ZY, Gupta GR, Wu WJ, Ravindranathan RA, Hervey-Jumper HS, Chang CS, Berger BM, Molinaro MA, Solomon SD. .
      View in: Publisher Site   Mentions:
    40. EXTH-68. SYSTEMIC NEUTRALIZATION OF IL6 SENSITIZES IDH-WILDTYPE GLIOBLASTOMA PRECLINICAL MODELS TO IMMUNE CHECKPOINT INHIBITION. Neuro-Oncology. 2023 Nov 10; 25(Supplement_5):v240-v240. Young YJ, Cho CN, Lucas LC, Mirchia MK, Seo SK, Chen CW, Nguyen NM, Chen CA, Phillips PJ, Ozawa OT, Bhaduri BA, Aghi AM, DeRisi DJ, Berger BM, Butowski BN, Spitzer SM, Raleigh RD. .
      View in: Publisher Site   Mentions:
    41. EPCO-28. MULTIPLATFORM MOLECULAR AND FUNCTIONAL GENOMIC ANALYSES OF NF1 MUTANT GLIOBLASTOMA IDENTIFY DISTINCT CO-MUTATION PATTERNS AND DRUGGABLE DEPENDENCIES UNDERLYING SELUMETINIB RESPONSE. Neuro-Oncology. 2023 Nov 10; 25(Supplement_5):v129-v130. Mirchia MK, Payne PE, Pan PS, Al-Adli AN, Young YJ, Chen CW, Pak PJ, Seo SK, Ozawa OT, Reddy RA, Perry PA, Liu LJ, Berger BM, Raleigh RD, Vasudevan VH. .
      View in: Publisher Site   Mentions:
    42. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Nat Med. 2023 Dec; 29(12):3067-3076. Chen WC, Choudhury A, Youngblood MW, Polley MC, Lucas CG, Mirchia K, Maas SLN, Suwala AK, Won M, Bayley JC, Harmanci AS, Harmanci AO, Klisch TJ, Nguyen MP, Vasudevan HN, McCortney K, Yu TJ, Bhave V, Lam TC, Pu JK, Li LF, Leung GK, Chan JW, Perlow HK, Palmer JD, Haberler C, Berghoff AS, Preusser M, Nicolaides TP, Mawrin C, Agnihotri S, Resnick A, Rood BR, Chew J, Young JS, Boreta L, Braunstein SE, Schulte J, Butowski N, Santagata S, Spetzler D, Bush NAO, Villanueva-Meyer JE, Chandler JP, Solomon DA, Rogers CL, Pugh SL, Mehta MP, Sneed PK, Berger MS, Horbinski CM, McDermott MW, Perry A, Bi WL, Patel AJ, Sahm F, Magill ST, Raleigh DR. PMID: 37944590; PMCID: PMC11073469.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    43. Insular Gliomas: A Review of Surgical Anatomy and Operative Considerations. Functional Anatomy of the Brain: A View from the Surgeon’s Eye. 2023 Oct 25; 211-218. Morshed MR, Young YJ, Haddad HA, Berger BM. .
      View in: Publisher Site   Mentions:
    44. Asleep triple-modality motor mapping for perirolandic gliomas: an update on outcomes. J Neurosurg. 2024 Apr 01; 140(4):1029-1037. Morshed RA, Cummins DD, Clark JP, Young JS, Haddad AF, Gogos AJ, Hervey-Jumper SL, Berger MS. PMID: 37856395.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. Adjuvant Chemoradiotherapy within One Year of Resection for Molecularly Defined Astrocytoma. International Journal of Radiation Oncology • Biology • Physics. 2023 Oct 1; 117(2):e130-e131. Liu LS, Chen CW, Zhang ZY, Young YJ, Morshed MR, Nguyen NM, Villanueva-Meyer VJ, Phillips PJ, Oberheim ON, Aghi AM, Sneed SP, Braunstein BS, de Groot dJ, Berger BM, Molinaro MA, Hervey-Jumper HS, Raleigh RD. .
      View in: Publisher Site   Mentions:
    46. JS05.7.A SURGICAL RE-RESECTION FOR RECURRENT GLIOBLASTOMA: PROGNOSTIC EVALUATION USING THE NOVEL RANO CLASSIFICATION FOR EXTENT OF RESECTION FROM THE RANORESECT GROUP. Neuro-Oncology. 2023 Sep 8; 25(Supplement_2):ii10-ii10. Karschnia KP, Dono DA, Young YJ, Juenger JS, Teske TN, Häni HL, Sciortino ST, Mau MC, Bruno BF, Nunez NL, Morshed MR, Haddad HA, Weller WM, van den Bent vM, Beck BJ, Hervey-Jumper HS, Molinaro MA, Tandon TN, Rudà RR, Vogelbaum VM, Bello BL, Schnell SO, Grau GS, Chang CS, Berger BM, Esquenazi EY, Tonn TJ. .
      View in: Publisher Site   Mentions:
    47. Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group. Neuro Oncol. 2023 09 05; 25(9):1672-1685. Karschnia P, Dono A, Young JS, Juenger ST, Teske N, Häni L, Sciortino T, Mau CY, Bruno F, Nunez L, Morshed RA, Haddad AF, Weller M, van den Bent M, Beck J, Hervey-Jumper S, Molinaro AM, Tandon N, Rudà R, Vogelbaum MA, Bello L, Schnell O, Grau SJ, Chang SM, Berger MS, Esquenazi Y, Tonn JC. PMID: 37253096; PMCID: PMC10479742.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    48. Glioma-neuronal circuit remodeling induces regional immunosuppression. bioRxiv. 2023 Aug 06. Nejo T, Krishna S, Jimenez C, Yamamichi A, Young JS, Lakshmanachetty S, Chen T, Phyu SSS, Ogino H, Watchmaker P, Diebold D, Choudhury A, Daniel AGS, Raleigh DR, Hervey-Jumper SL, Okada H. PMID: 37577659; PMCID: PMC10418167.
      View in: PubMed   Mentions:
    49. Analysis of upfront resection or stereotactic radiosurgery for local control of solid and cystic cerebellar hemangioblastomas. J Neurosurg. 2024 02 01; 140(2):404-411. Carrete LR, Morshed RA, Young JS, Avalos LN, Sneed PK, Aghi MK, McDermott MW, Theodosopoulos PV. PMID: 37542443.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy. JAMA Netw Open. 2023 08 01; 6(8):e2329186. Vasudevan HN, Delley C, Chen WC, Mirchia K, Pan S, Shukla P, Aabedi AA, Nguyen MP, Morshed RA, Young JS, Boreta L, Fogh SE, Nakamura JL, Theodosopoulos PV, Phillips J, Hervey-Jumper SL, Daras M, Pike L, Aghi MK, Tsai K, Raleigh DR, Braunstein SE, Abate AR. PMID: 37589977; PMCID: PMC10436135.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    51. High-volume facilities are not always low risk: comparing risk-standardized mortality rates versus facility volume as quality measures in surgical neuro-oncology. J Neurosurg. 2024 01 01; 140(1):10-17. Chalif EJ, Young JS, Villa GR, Aghi MK, Lenzi J, Berger MS. PMID: 37410629.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    52. Does waiting for surgery matter? How time from diagnostic MRI to resection affects outcomes in newly diagnosed glioblastoma. J Neurosurg. 2024 01 01; 140(1):80-93. Young JS, Al-Adli NN, Muster R, Chandra A, Morshed RA, Pereira MP, Chalif EJ, Hervey-Jumper SL, Theodosopoulos PV, McDermott MW, Berger MS, Aghi MK. PMID: 37382331; PMCID: PMC11180214.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    53. Prognostic evaluation of surgical re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group. Journal of Clinical Oncology. 2023 Jun 1; 41(16_suppl):2010-2010. Karschnia KP, Dono DA, Young YJ, Jünger JS, Teske TN, Häni HL, Sciortino ST, Mau MC, Bruno BF, Weller WM, Ruda RR, Vogelbaum VM, Bello BL, Schnell SO, Grau GS, Chang CS, Berger BM, Esquenazi EY, Tonn TJ. .
      View in: Publisher Site   Mentions:
    54. Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group. Neuro Oncol. 2023 05 04; 25(5):940-954. Karschnia P, Young JS, Dono A, Häni L, Sciortino T, Bruno F, Juenger ST, Teske N, Morshed RA, Haddad AF, Zhang Y, Stoecklein S, Weller M, Vogelbaum MA, Beck J, Tandon N, Hervey-Jumper S, Molinaro AM, Rudà R, Bello L, Schnell O, Esquenazi Y, Ruge MI, Grau SJ, Berger MS, Chang SM, van den Bent M, Tonn JC. PMID: 35961053; PMCID: PMC10158281.
      View in: PubMed   Mentions: 116     Fields:    Translation:Humans
    55. Technical Aspects of Motor and Language Mapping in Glioma Patients. Cancers (Basel). 2023 Apr 06; 15(7). Al-Adli NN, Young JS, Sibih YE, Berger MS. PMID: 37046834; PMCID: PMC10093517.
      View in: PubMed   Mentions: 6  
    56. A Preoperative Scoring System to Predict Function-Based Resection Limitation Due to Insufficient Participation During Awake Surgery. Neurosurgery. 2023 09 01; 93(3):678-690. Elia A, Young JS, Simboli GA, Roux A, Moiraghi A, Trancart B, Al-Adli N, Aboubakr O, Bedioui A, Leclerc A, Planet M, Parraga E, Benevello C, Oppenheim C, Chretien F, Dezamis E, Berger MS, Zanello M, Pallud J. PMID: 37018385.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    57. Abstract 2497: Glioma-induced neuronal remodeling promotes regional immunosuppression. Cancer Research. 2023 Apr 4; 83(7_Supplement):2497-2497. Nejo NT, Krishna KS, Jimenez JC, Yamamichi YA, Young YJ, Chen CT, Lakshmanachetty LS, Watchmaker WP, Choudhury CA, Ogino OH, Raleigh RD, Hervey-Jumper HS, Okada OH. .
      View in: Publisher Site   Mentions:
    58. 885 Reprogramming the Glioblastoma Immune Microenvironment With Convection Enhanced Gene Therapy Reveals Intratumor IL6 Drives Glioblastoma Immunosuppression and Growth. Neurosurgery. 2023 Apr 1; 69(Supplement_1):51-51. Young YJ, Cho CN, Lucas LC, Seo SK, Santos SR, Liu LS, Phillips PJ, Ozawa OT, Bhaduri BA, Aghi AM, Berger BM, Raleigh RD. .
      View in: Publisher Site   Mentions:
    59. 886 Stereotactic Radiosurgery Reprograms Macrophage, Microglia, and T Cell Populations in the Glioblastoma Immune Microenvironment. Neurosurgery. 2023 Apr 1; 69(Supplement_1):51-52. Young YJ, Cho CN, Lucas LC, Seo SK, Santos SR, Phillips PJ, Ozawa OT, Berger BM, Raleigh RD. .
      View in: Publisher Site   Mentions:
    60. 880 Electrophysiological Patterns of Glioma-Induced Neuronal Network Remodeling are a General Property of Brain Tumors Regardless of Subtype. Neurosurgery. 2023 Apr 1; 69(Supplement_1):50-50. Aabedi AA, Lipkin LB, Young YJ, Hinkley HL, Findlay FA, Daniel DA, Krishna KS, Umbach UG, Surapaneni SA, Kaur KJ, Berger BM, Molinaro MA, Brang BD, Nagarajan NS, Hervey-Jumper HS. .
      View in: Publisher Site   Mentions:
    61. Glioblastoma induces the recruitment and differentiation of hybrid neutrophils from skull bone marrow. bioRxiv. 2023 Mar 25. Lad BM, Beniwal AS, Jain S, Shukla P, Jung J, Shah SS, Yagnik G, Babikir H, Nguyen AT, Gill S, Young JS, Lui A, Salha D, Diaz A, Aghi MK. PMID: 36993266; PMCID: PMC10055347.
      View in: PubMed   Mentions:
    62. Pseudoprogression versus true progression in glioblastoma: what neurosurgeons need to know. J Neurosurg. 2023 09 01; 139(3):748-759. Young JS, Al-Adli N, Scotford K, Cha S, Berger MS. PMID: 36790010; PMCID: PMC10412732.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    63. CDKN2A/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad007. Morshed RA, Nguyen MP, Cummins DD, Saggi S, Young JS, Haddad AF, Goldschmidt E, Chang EF, McDermott MW, Berger MS, Theodosopoulos PV, Hervey-Jumper SL, Daras M, Aghi MK. PMID: 36915611; PMCID: PMC10007908.
      View in: PubMed   Mentions: 4  
    64. Identification of risk factors associated with leptomeningeal disease after resection of brain metastases. J Neurosurg. 2023 08 01; 139(2):402-413. Morshed RA, Saggi S, Cummins DD, Molinaro AM, Young JS, Viner JA, Villanueva-Meyer JE, Goldschmidt E, Boreta L, Braunstein SE, Chang EF, McDermott MW, Berger MS, Theodosopoulos PV, Hervey-Jumper SL, Aghi MK, Daras M. PMID: 36640095; PMCID: PMC11208084.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    65. Recent advances in the molecular prognostication of meningiomas. Front Oncol. 2022; 12:910199. Wang EJ, Haddad AF, Young JS, Morshed RA, Wu JPH, Salha DM, Butowski N, Aghi MK. PMID: 36686824; PMCID: PMC9845914.
      View in: PubMed   Mentions: 4  
    66. Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma. J Clin Oncol. 2023 04 10; 41(11):2029-2042. Hervey-Jumper SL, Zhang Y, Phillips JJ, Morshed RA, Young JS, McCoy L, Lafontaine M, Luks T, Ammanuel S, Kakaizada S, Egladyous A, Gogos A, Villanueva-Meyer J, Shai A, Warrier G, Rice T, Crane J, Wrensch M, Wiencke JK, Daras M, Oberheim Bush NA, Taylor JW, Butowski N, Clarke J, Chang S, Chang E, Aghi M, Theodosopoulos P, McDermott M, Jakola AS, Kavouridis VK, Nawabi N, Solheim O, Smith T, Berger MS, Molinaro AM. PMID: 36599113; PMCID: PMC10082290.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    67. Evaluation Of Surgical Resection for Recurrent Glioblastoma Using The RANO Classification For Extent Of Resection: A Report Of The RANO Resect Group. Brain and Spine. 2023 Jan 1; 3:101849. Karschnia KP, Dono DA, Young YJ, Jünger JS, Teske TN, Häni HL, Sciortino ST, Mau MC, Bruno BF, Weller WM, Rudà RR, Vogelbaum VM, Bello BL, Schnell SO, Grau GS, Chang CS, Berger BM, Esquenazi EY, Tonn TJ, investigators iR. .
      View in: Publisher Site   Mentions:
    68. BIOM-02. MUTATIONAL ANALYSIS AND SINGLE CELL SEQUENCING OF MELANOMA BRAIN METASTASES REVEALS BRAF STATUS CORRELATES WITH CLINICAL OUTCOME AND DIFFERENTIAL IMMUNE POPULATIONS. Neuro-Oncology. 2022 Nov 14; 24(Supplement_7):vii3-vii4. Vasudevan VH, Delley DC, Aabedi AA, Shukla SP, Nguyen NM, Morshed MR, Young YJ, Demaree DB, Diwanji DD, Hervey-Jumper HS, Boreta BL, Fogh FS, Nakamura NJ, Theodospoulos TP, Phillips PJ, Daras DM, Tsai TK, Sneed SP, Aghi AM, Raleigh RD, Braunstein BS, Abate AA. .
      View in: Publisher Site   Mentions:
    69. SURG-05. SUPERVISED MACHINE LEARNING IDENTIFIES RISK FACTORS ASSOCIATED WITH LEPTOMENINGEAL DISEASE AFTER SURGICAL RESECTION OF BRAIN METASTASES. Neuro-Oncology. 2022 Nov 14; 24(Supplement_7):vii251-vii252. Morshed MR, Saggi SS, Cummins CD, Young YJ, Viner VJ, Villanueva-Meyer VJ, Goldschmidt GE, Boreta BL, Braunstein BS, Chang CE, McDermott MM, Berger BM, Theodospoulos TP, Hervey-Jumper HS, Aghi AM, Daras DM. .
      View in: Publisher Site   Mentions:
    70. CNSC-19. GLIOMA-INDUCED NEURONAL REMODELING PROMOTES REGIONAL IMMUNOSUPPRESSION. Neuro-Oncology. 2022 Nov 14; 24(Supplement_7):vii26-vii26. Nejo NT, Krishna KS, Young YJ, Yamamichi YA, Jimenez JC, Chen CT, Watchmaker WP, Choudhury CA, Diebold DD, Ogino OH, Raleigh RD, Hervey-Jumper HS, Okada OH. .
      View in: Publisher Site   Mentions:
    71. CNSC-05. ELECTROPHYSIOLOGICAL PATTERNS OF GLIOMA-INDUCED NEURONAL NETWORK REMODELING ARE CONSERVED ACROSS TUMOR SUBTYPE. Neuro-Oncology. 2022 Nov 14; 24(Supplement_7):vii22-vii22. Aabedi AA, Lipkin LB, Young YJ, Hinkley HL, Findlay FA, Daniel DA, Krishna KS, Umbach UG, Kaur KJ, Berger BM, Molinaro MA, Brang BD, Nagarajan NS, Hervey-Jumper HS. .
      View in: Publisher Site   Mentions:
    72. SURG-04. CDK2NA/B, SMAD4, AND PIK3R1 MUTATIONS ARE ASSOCIATED WITH INCREASED RISK OF LOCAL RECURRENCE AFTER SURGICAL RESECTION OF BRAIN METASTASES. Neuro-Oncology. 2022 Nov 14; 24(Supplement_7):vii251-vii251. Morshed MR, Cummins CD, Nguyen NM, Young YJ, Theodospoulos TP, Hervey-Jumper HS, Aghi AM, Daras DM. .
      View in: Publisher Site   Mentions:
    73. RBIO-04. STEREOTACTIC RADIOSURGERY REPROGRAMS MACROPHAGE, MICROGLIA, AND CD8+ T CELL POPULATIONS IN THE GLIOBLASTOMA IMMUNE MICROENVIRONMENT. Neuro-Oncology. 2022 Nov 14; 24(Supplement_7):vii247-vii248. Young YJ, Cho CN, Lucas LC, Seo SK, Santos SR, Phillips PJ, Ozawa OT, Berger BM, Raleigh RD. .
      View in: Publisher Site   Mentions:
    74. TMIC-36. REPROGRAMMING THE GLIOBLASTOMA IMMUNE MICROENVIRONMENT WITH CONVECTION ENHANCED GENE THERAPY REVEALS INTRATUMOR IL6 DRIVES GLIOBLASTOMA IMMUNOSUPPRESSION AND GROWTH. Neuro-Oncology. 2022 Nov 14; 24(Supplement_7):vii279-vii279. Young YJ, Cho CN, Lucas LC, Seo SK, Santos SR, Liu LS, Phillips PJ, Ozawa OT, Bhaduri BA, Aghi AM, Berger BM, Raleigh RD. .
      View in: Publisher Site   Mentions:
    75. BIOM-31. TEMPOROSPATIAL PROTEIN PROFILING OF HUMAN GLIOBLASTOMAS REVEALS MOLECULAR MECHANISMS AND BIOMARKERS UNDERLYING RESPONSES TO IMMUNE CHECKPOINT INHIBITION. Neuro-Oncology. 2022 Nov 14; 24(Supplement_7):vii11-vii11. Young YJ, Lucas LC, Seo SK, Nguyen NM, Chen CW, Solomon SD, Berger BM, Phillips PJ, Aghi AM, Raleigh RD. .
      View in: Publisher Site   Mentions:
    76. Transsphenoidal Surgery for Acromegaly. Acromegaly. 2022 Nov 13; 167-184. Phelps PR, Young YJ, Gurrola GJ, Aghi AM. .
      View in: Publisher Site   Mentions:
    77. Recognizing the psychological impact of a glioma diagnosis on mental and behavioral health: a systematic review of what neurosurgeons need to know. J Neurosurg. 2023 07 01; 139(1):11-19. Young JS, Al-Adli N, Sibih YE, Scotford KL, Casey M, James S, Berger MS. PMID: 36334288; PMCID: PMC10413205.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    78. Mutational Analysis and Single Cell Sequencing of Melanoma Brain Metastases. International Journal of Radiation Oncology • Biology • Physics. 2022 Nov 1; 114(3):e63-e64. Vasudevan VH, Delley DC, Aabedi AA, Nguyen NM, Morshed MR, Young YJ, Demaree DB, Diwanji DD, Hervey-Jumper HS, Boreta BL, Fogh FS, Nakamura NJ, Theodosopoulos TP, Phillips PJ, Daras DM, Tsai TK, Sneed SP, Aghi AM, Raleigh RD, Braunstein BS, Abate AA. .
      View in: Publisher Site   Mentions:
    79. Timing of Adjuvant Radiotherapy and Survival Analysis for Molecularly Defined Low Grade Glioma. International Journal of Radiation Oncology • Biology • Physics. 2022 Nov 1; 114(3):e75. Liu LS, Chen CW, Zhang ZY, Young YJ, Morshed MR, Villanueva-Meyer VJ, Phillips PJ, Oberheim ON, Aghi AM, Sneed SP, Braunstein BS, Berger BM, Molinaro MA, Hervey-Jumper HS, Raleigh RD. .
      View in: Publisher Site   Mentions:
    80. Chronic convection-enhanced intratumoural delivery of chemotherapy for glioblastoma. Lancet Oncol. 2022 11; 23(11):1347-1348. Young JS, Aghi MK. PMID: 36243021; PMCID: PMC10314796.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    81. A case (report) for mechanistic validation of meningioma molecular therapies. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac162. Nguyen MP, Seo K, Eaton CD, Lucas CG, Chen WC, Choudhury A, Young JS, Raleigh DR. PMID: 36382111; PMCID: PMC9639353.
      View in: PubMed   Mentions: 2  
    82. Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomes. Neuro Oncol. 2022 10 03; 24(10):1749-1762. Zhang Y, Lucas CG, Young JS, Morshed RA, McCoy L, Oberheim Bush NA, Taylor JW, Daras M, Butowski NA, Villanueva-Meyer JE, Cha S, Wrensch M, Wiencke JK, Lee JC, Pekmezci M, Phillips JJ, Perry A, Bollen AW, Aghi MK, Theodosopoulos P, Chang EF, Hervey-Jumper SL, Berger MS, Clarke JL, Chang SM, Molinaro AM, Solomon DA. PMID: 35395677; PMCID: PMC9527525.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    83. TERT promotor status does not add prognostic information in IDH-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO resect group. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac158. Karschnia P, Young JS, Dono A, Häni L, Juenger ST, Sciortino T, Bruno F, Teske N, Morshed RA, Haddad AF, Zhang Y, Stoecklein S, Vogelbaum MA, Beck J, Tandon N, Hervey-Jumper S, Molinaro AM, Rudà R, Bello L, Schnell O, Esquenazi Y, Ruge MI, Grau SJ, van den Bent M, Weller M, Berger MS, Chang SM, Tonn JC. PMID: 36325373; PMCID: PMC9616057.
      View in: PubMed   Mentions: 4  
    84. OS07.6.A Extent of resection in glioblastoma: refinement and prognostic validation of a classification system from the RANO resect group. Neuro-Oncology. 2022 Sep 5; 24(Supplement_2):ii17-ii17. Karschnia KP, Young YJ, Dono DA, Häni HL, Sciortino ST, Bruno BF, Jünger JS, Teske TN, Weller WM, Rudà RR, Bello BL, Schnell SO, Esquenazi EY, Grau GS, Molinaro MA, Berger BM, Chang CS, van den Bent vM, Tonn TJ. .
      View in: Publisher Site   Mentions:
    85. LOCL-06 SUPERVISED MACHINE LEARNING IDENTIFIES RISK FACTORS ASSOCIATED WITH LEPTOMENINGEAL DISEASE AFTER SURGICAL RESECTION OF BRAIN METASTASES. Neuro-Oncology Advances. 2022 Aug 5; 4(Suppl 1):i12-i13. Morshed MR, Saggi SS, Cummins CD, Young YJ, Viner VJ, Villanueva-Meyer VJ, Boreta BL, Braunstein BS, McDermott MM, Theodosopoulos TP, Berger BM, Hervey-Jumper HS, Aghi AM, Daras DM. .
      View in: Publisher Site   Mentions:
    86. CDK 4/6 inhibitors for the treatment of meningioma. Front Oncol. 2022; 12:931371. Young JS, Kidwell RL, Zheng A, Haddad AF, Aghi MK, Raleigh DR, Schulte JD, Butowski NA. PMID: 35936751; PMCID: PMC9354681.
      View in: PubMed   Mentions: 8  
    87. Involvement of White Matter Language Tracts in Glioma: Clinical Implications, Operative Management, and Functional Recovery After Injury. Front Neurosci. 2022; 16:932478. Aabedi AA, Young JS, Chang EF, Berger MS, Hervey-Jumper SL. PMID: 35898410; PMCID: PMC9309688.
      View in: PubMed   Mentions: 10  
    88. Machine learning for predicting hemorrhage in pediatric patients with brain arteriovenous malformation. J Neurosurg Pediatr. 2022 08 01; 30(2):203-209. Saggi S, Winkler EA, Ammanuel SG, Morshed RA, Garcia JH, Young JS, Semonche A, Fullerton HJ, Kim H, Cooke DL, Hetts SW, Abla A, Lawton MT, Gupta N. PMID: 35916099.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    89. Convection-delivered adenoviral gene therapy reprograms the immunosuppressive glioblastoma microenvironment. Journal of Clinical Oncology. 2022 Jun 1; 40(16_suppl):2039-2039. Young YJ, Cho CN, Casey-Clyde CT, Santos SR, Seo SK, Phillips PJ, Berger BM, Ozawa OT, Raleigh RD. .
      View in: Publisher Site   Mentions:
    90. Prognostic validation and refinement of a classification system for extent of resection in glioblastoma: A report of the RANO resect group. Journal of Clinical Oncology. 2022 Jun 1; 40(16_suppl):2003-2003. Karschnia KP, Young YJ, Dono DA, Häni HL, Sciortino ST, Bruno BF, Jünger JS, Teske TN, Weller WM, Ruda RR, Bello BL, Schnell SO, Esquenazi EY, Grau GS, Molinaro MA, Berger BM, Chang CS, Van Den Bent VM, Tonn TJ. .
      View in: Publisher Site   Mentions:
    91. A targeted gene expression biomarker and association with meningioma outcomes and radiotherapy. Journal of Clinical Oncology. 2022 Jun 1; 40(16_suppl):2007-2007. Chen CW, Choudhury CA, Vasudevan VH, Lucas LC, Nguyen NM, Young YJ, Yu YT, Chan CJ, Oberheim Bush ON, Schulte SJ, Villanueva-Meyer VJ, Braunstein BS, Butowski BN, Sneed SP, Berger BM, Perry PA, Solomon SD, McDermott MM, Magill MS, Raleigh RD. .
      View in: Publisher Site   Mentions:
    92. Factors associated with preoperative and postoperative seizures in patients undergoing resection of brain metastases. J Neurosurg. 2023 01 01; 138(1):19-26. Garcia JH, Morshed RA, Chung J, Millares Chavez MA, Sudhakar V, Saggi S, Avalos LN, Gallagher A, Young JS, Daras M, McDermott MW, Garcia PA, Chang EF, Aghi MK. PMID: 35535842.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    93. Pituitary adenoma in the elderly: surgical outcomes and treatment trends in the United States. J Neurosurg. 2022 12 01; 137(6):1687-1698. Chalif EJ, Morshed RA, Young JS, Haddad AF, Jain S, Aghi MK. PMID: 35535847.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    94. FLAIRectomy: Resecting beyond the Contrast Margin for Glioblastoma. Brain Sci. 2022 Apr 25; 12(5). Haddad AF, Young JS, Morshed RA, Berger MS. PMID: 35624931; PMCID: PMC9139350.
      View in: PubMed   Mentions: 24  
    95. The benefit of early surgery on overall survival in incidental low-grade glioma patients: A multicenter study. Neuro Oncol. 2022 04 01; 24(4):624-638. Ius T, Ng S, Young JS, Tomasino B, Polano M, Ben-Israel D, Kelly JJP, Skrap M, Duffau H, Berger MS. PMID: 34498069; PMCID: PMC8972318.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    96. Surgery for Control of Brain Metastases After Previous Checkpoint Inhibitor Immunotherapy. World Neurosurg. 2022 06; 162:e235-e245. Morshed RA, Chung JE, Cummins DD, Sudhakar V, Young JS, Daras M, Hervey-Jumper SL, Theodosopoulos PV, Aghi MK. PMID: 35288357.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    97. Resistance to immune checkpoint blockade: Mechanisms, counter-acting approaches, and future directions. Semin Cancer Biol. 2022 11; 86(Pt 3):532-541. Haddad AF, Young JS, Gill S, Aghi MK. PMID: 35276342; PMCID: PMC9458771.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    98. Advanced Imaging Techniques for Newly Diagnosed and Recurrent Gliomas. Front Neurosci. 2022; 16:787755. Carrete LR, Young JS, Cha S. PMID: 35281485; PMCID: PMC8904563.
      View in: PubMed   Mentions: 14  
    99. Sarcopenia Diagnosed Using Masseter Muscle Diameter as a Survival Correlate in Elderly Patients with Glioblastoma. World Neurosurg. 2022 05; 161:e448-e463. Morshed RA, Young JS, Casey M, Wang EJ, Aghi MK, Berger MS, Hervey-Jumper SL. PMID: 35181534; PMCID: PMC9284942.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    100. The immunology of low-grade gliomas. Neurosurg Focus. 2022 02; 52(2):E2. Haddad AF, Young JS, Oh JY, Okada H, Aghi MK. PMID: 35104791; PMCID: PMC9283531.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    101. Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type Glioblastoma. Neurosurgery. 2022 01 01; 90(1):124-130. Aabedi AA, Young JS, Zhang Y, Ammanuel S, Morshed RA, Dalle Ore C, Brown D, Phillips JJ, Oberheim Bush NA, Taylor JW, Butowski N, Clarke J, Chang SM, Aghi M, Molinaro AM, Berger MS, Hervey-Jumper SL. PMID: 34982879; PMCID: PMC9514750.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    102. Reducing complication rates for repeat craniotomies in glioma patients: a single-surgeon experience and comparison with the literature. Acta Neurochir (Wien). 2022 02; 164(2):405-417. Morshed RA, Young JS, Gogos AJ, Haddad AF, McMahon JT, Molinaro AM, Sudhakar V, Al-Adli N, Hervey-Jumper SL, Berger MS. PMID: 34970702; PMCID: PMC8854329.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    103. Pseudo-insular glioma syndrome: illustrative cases. J Neurosurg Case Lessons. 2021 Dec 27; 2(26):CASE21481. Haddad AF, Young JS, Morshed RA, Josephson SA, Cha S, Berger MS. PMID: 35854917; PMCID: PMC9281470.
      View in: PubMed   Mentions: 1  
    104. Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type Glioblastoma. Neurosurgery. 2021 Nov 29; Publish Ahead of Print. Aabedi AA, Young YJ, Zhang ZY, Ammanuel AS, Morshed MR, Dalle Ore DC, Brown BD, Phillips PJ, Oberheim Bush ON, Taylor TJ, Butowski BN, Clarke CJ, Chang CS, Aghi AM, Molinaro MA, Berger BM, Hervey-Jumper HS. .
      View in: Publisher Site   Mentions:
    105. Functional outcomes after resection of middle frontal gyrus diffuse gliomas. J Neurosurg. 2022 Jul 01; 137(1):1-8. Morshed RA, Lee AT, Wang EJ, Young JS, Cha S, Hervey-Jumper SL, Berger MS. PMID: 34798608.
      View in: PubMed   Mentions: 6     Fields:    
    106. Functional alterations in cortical processing of speech in glioma-infiltrated cortex. Proc Natl Acad Sci U S A. 2021 11 16; 118(46). Aabedi AA, Lipkin B, Kaur J, Kakaizada S, Valdivia C, Reihl S, Young JS, Lee AT, Krishna S, Berger MS, Chang EF, Brang D, Hervey-Jumper SL. PMID: 34753819; PMCID: PMC8609626.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    107. TAMI-66. FUNCTIONAL ALTERATIONS IN CORTICAL PROCESSING OF SPEECH IN GLIOMA-INFILTRATED CORTEX. Neuro-Oncology. 2021 Nov 12; 23(Supplement_6):vi212-vi212. Aabedi Aa, Lipkin LB, Kaur KJ, Kakaizada KS, Young YJ, Lee LA, Krishna KS, Chang CE, Brang BD, Hervey-Jumper HS. .
      View in: Publisher Site   Mentions:
    108. BIOM-40. TARGETED GENE EXPRESSION PROFILING PREDICTS MENINGIOMA OUTCOMES AND RADIOTHERAPY RESPONSES. Neuro-Oncology. 2021 Nov 12; 23(Supplement_6):vi19-vi20. Chen CW, Choudhury CA, Vasudevan VH, Lucas LC, Nguyen NM, Young YJ, Yu YT, Lam LT, Pu PJ, Li LL, Leung LG, Chan CJ, Oberheim-Bush ON, Villanueva-Meyer VJ, Schulte SJ, Braunstein BS, Butowski BN, Sneed SP, Berger BM, Perry PA, Solomon SD, McDermott MM, Magill MS, Raleigh RD. .
      View in: Publisher Site   Mentions:
    109. EXTH-13. LOCAL DELIVERY OF AN IL-15 SUPERAGONIST USING A REPLICATING RETROVIRUS SIGNIFICANTLY IMPROVES SURVIVAL AND LYMPHOCYTE INFILTRATION IN POORLY IMMUNOGENIC MURINE GLIOBLASTOMA MODELS. Neuro-Oncology. 2021 Nov 12; 23(Supplement_6):vi166-vi166. Haddad HA, Spatz SJ, Montoya MM, Collins CS, Gill GS, Wang WE, Chuntova CP, Young YJ, Kasahara KN, Aghi AM. .
      View in: Publisher Site   Mentions:
    110. TWMP-01. RESECTION OF SUPPLEMENTARY MOTOR AREA GLIOMAS: REVISITING SUPPLEMENTARY MOTOR SYNDROME AND THE ROLE OF THE FRONTAL ASLANT TRACT. Neuro-Oncology. 2021 Nov 12; 23(Supplement_6):vi230-vi230. Young YJ, Gogos GA, Aabedi AA, Morshed MR, Pereira PM, Lashof-Regas LS, Mansoori MZ, Luks LT, Hervey-Jumper HS, Villanueva-Meyer VJ, Berger BM. .
      View in: Publisher Site   Mentions:
    111. SURG-08. SARCOPENIA IS A PROGNOSTIC FACTOR OF 90-DAY MORTALITY AND OVERALL SURVIVAL IN ELDERLY PATIENTS WITH GLIOBLASTOMA. Neuro-Oncology. 2021 Nov 12; 23(Supplement_6):vi196-vi196. Morshed MR, Young YJ, Casey CM, Wang WE, Aghi AM, Berger BM, Hervey-Jumper HS. .
      View in: Publisher Site   Mentions:
    112. Comparing the Quality of Life after Brain Injury-Overall Scale and Satisfaction with Life Scale as Outcome Measures for Traumatic Brain Injury Research. J Neurotrauma. 2021 12; 38(23):3352-3363. Kreitzer N, Jain S, Young JS, Sun X, Stein MB, McCrea MA, Levin HS, Giacino JT, Markowitz AJ, Manley GT, Nelson LD, Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Investigators. PMID: 34435894; PMCID: PMC8820285.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    113. Facial pain and sensory outcomes following resection of tumors compressing the trigeminal nerve. J Neurosurg. 2022 04 01; 136(4):1119-1127. Castro MRH, Magill ST, Morshed RA, Young JS, Braunstein SE, McDermott MW, Chang EF. PMID: 34624867.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    114. Resection of supplementary motor area gliomas: revisiting supplementary motor syndrome and the role of the frontal aslant tract. J Neurosurg. 2022 May 01; 136(5):1278-1284. Young JS, Gogos AJ, Aabedi AA, Morshed RA, Pereira MP, Lashof-Regas S, Mansoori Z, Luks T, Hervey-Jumper SL, Villanueva-Meyer JE, Berger MS. PMID: 34598138.
      View in: PubMed   Mentions: 12     Fields:    
    115. Comparison of Outcomes following Primary and Repeat Resection of Craniopharyngioma. Journal of Neurological Surgery Part B Skull Base. 2021 Sep 10. Aabedi AA, Young YJ, Phelps PR, Winkler WE, McDermott MM, Theodosopoulos TP. .
      View in: Publisher Site   Mentions:
    116. Comparison of Outcomes following Primary and Repeat Resection of Craniopharyngioma. J Neurol Surg B Skull Base. 2022 Jun; 83(Suppl 2):e545-e554. Aabedi AA, Young JS, Phelps RRL, Winkler EA, McDermott MW, Theodosopoulos PV. PMID: 35832950; PMCID: PMC9272314.
      View in: PubMed   Mentions: 1  
    117. Prosopagnosia following nonlanguage dominant inferior temporal lobe low-grade glioma resection in which the inferior longitudinal fasciculus was disrupted preoperatively: illustrative case. J Neurosurg Case Lessons. 2021 Sep 06; 2(10):CASE21277. Young JS, Morshed RA, Andrews JP, Cha S, Berger MS. PMID: 35855186; PMCID: PMC9265231.
      View in: PubMed   Mentions: 4  
    118. Prosopagnosia following nonlanguage dominant inferior temporal lobe low-grade glioma resection in which the inferior longitudinal fasciculus was disrupted preoperatively: illustrative case. . 2021 Sep 6; 2(10). Young YJ, Morshed MR, Andrews AJ, Cha CS, Berger BM. .
      View in: Publisher Site   Mentions:
    119. A Review of Cortical and Subcortical Stimulation Mapping for Language. Neurosurgery. 2021 08 16; 89(3):331-342. Young JS, Lee AT, Chang EF. PMID: 33444451; PMCID: PMC8492609.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    120. SURG-11. Surgery for control of brain metastases after prior checkpoint inhibitor immunotherapy: a single-center series. Neuro-Oncology Advances. 2021 Aug 9; 3(Suppl 3):iii25-iii26. Morshed MR, Chung CJ, Sudhakar SV, Cummins CD, Young YJ, Hervey-Jumper HS, Theodosopoulos TP, Aghi AM. .
      View in: Publisher Site   Mentions:
    121. Mouse models of glioblastoma for the evaluation of novel therapeutic strategies. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab100. Haddad AF, Young JS, Amara D, Berger MS, Raleigh DR, Aghi MK, Butowski NA. PMID: 34466804; PMCID: PMC8403483.
      View in: PubMed   Mentions: 76  
    122. Mouse Models of Glioblastoma for the Evaluation of Novel Therapeutic Strategies. Neuro-Oncology Advances. 2021 Jul 26; vdab100-. Haddad HA, Young YJ, Amara AD, Berger BM, Raleigh RD, Aghi AM, Butowski BN. .
      View in: Publisher Site   Mentions:
    123. Clinical Pearls and Methods for Intraoperative Awake Language Mapping. Neurosurgery. 2021 07 15; 89(2):143-153. Morshed RA, Young JS, Lee AT, Berger MS, Hervey-Jumper SL. PMID: 33289505; PMCID: PMC8279835.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    124. A Neurosurgeon's Guide to Cognitive Dysfunction in Adult Glioma. Neurosurgery. 2021 06 15; 89(1):1-10. Morshed RA, Young JS, Kroliczek AA, Berger MS, Brang D, Hervey-Jumper SL. PMID: 33289504; PMCID: PMC8203420.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    125. A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma. J Neurooncol. 2021 Jul; 153(3):447-454. Bush NAO, Young JS, Zhang Y, Dalle Ore CL, Molinaro AM, Taylor J, Clarke J, Prados M, Braunstein SE, Raleigh DR, Chang SM, Berger MS, Butowski NA. PMID: 34125374; PMCID: PMC8279971.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    126. Detection of glioma infiltration at the tumor margin using quantitative stimulated Raman scattering histology. Sci Rep. 2021 06 09; 11(1):12162. Pekmezci M, Morshed RA, Chunduru P, Pandian B, Young J, Villanueva-Meyer JE, Tihan T, Sloan EA, Aghi MK, Molinaro AM, Berger MS, Hervey-Jumper SL. PMID: 34108566; PMCID: PMC8190264.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    127. Balancing task sensitivity with reliability for multimodal language assessments. J Neurosurg. 2021 12 01; 135(6):1817-1824. Aabedi AA, Kakaizada S, Young JS, Ahn E, Weissman DH, Berger MS, Brang D, Hervey-Jumper SL. PMID: 34049284; PMCID: PMC10404475.
      View in: PubMed   Mentions: 4     Fields:    
    128. Oncology and Spinal Neurosurgeons Performing Resections of Intramedullary Ependymomas Compared with Single Neurosurgeons: A 13-Year Experience at a Single Institution. World Neurosurg. 2021 08; 152:e212-e219. Nichols NM, Young JS, Magill ST, Morshed RA, Aabedi AA, Chou D, Mummaneni PV, McDermott MW, Theodosopoulos PV. PMID: 34058361.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    129. Letter: COVID Conundrum: Postoperative COVID-19 Infections Following Endonasal Transsphenoidal Pituitary Surgery. Neurosurgery. 2021 05 13; 88(6):E571-E572. Young JS, Oh T, Arora T, Blevins LS, Aghi MK, El-Sayed IH, Kunwar S, Theodosopoulos PV. PMID: 33693893; PMCID: PMC7989194.
      View in: PubMed   Mentions: 1     Fields:    
    130. The Relationship Between Stimulation Current and Functional Site Localization During Brain Mapping. Neurosurgery. 2021 05 13; 88(6):1043-1050. Muster RH, Young JS, Woo PYM, Morshed RA, Warrier G, Kakaizada S, Molinaro AM, Berger MS, Hervey-Jumper SL. PMID: 33289525; PMCID: PMC8117445.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    131. Convergence of heteromodal lexical retrieval in the lateral prefrontal cortex. Sci Rep. 2021 03 18; 11(1):6305. Aabedi AA, Kakaizada S, Young JS, Kaur J, Wiese O, Valdivia C, Krishna S, Weyer-Jamora C, Berger MS, Weissman DH, Brang D, Hervey-Jumper SL. PMID: 33737672; PMCID: PMC7973515.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    132. Commentary: Planning Brain Tumor Resection Using a Probabilistic Atlas of Cortical and Subcortical Structures Critical for Functional Processing: A Proof of Concept. Oper Neurosurg (Hagerstown). 2021 02 16; 20(3):E184-E185. Morshed RA, Young JS, Hervey-Jumper SL. PMID: 33432976.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    133. Using viral vectors to deliver local immunotherapy to glioblastoma. Neurosurg Focus. 2021 02; 50(2):E4. Haddad AF, Young JS, Aghi MK. PMID: 33524947; PMCID: PMC8011938.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    134. Preoperative Applications of Navigated Transcranial Magnetic Stimulation. Front Neurol. 2020; 11:628903. Haddad AF, Young JS, Berger MS, Tarapore PE. PMID: 33551983; PMCID: PMC7862711.
      View in: PubMed   Mentions: 27  
    135. Effects of ventricular entry on patient outcome during glioblastoma resection. J Neurosurg. 2021 10 01; 135(4):989-997. Young JS, Gogos AJ, Pereira MP, Morshed RA, Li J, Barkovich MJ, Hervey-Jumper SL, Berger MS. PMID: 33418530.
      View in: PubMed   Mentions: 6     Fields:    
    136. Immunologic aspects of viral therapy for glioblastoma and implications for interactions with immunotherapies. J Neurooncol. 2021 Mar; 152(1):1-13. Haddad AF, Young JS, Mummaneni NV, Kasahara N, Aghi MK. PMID: 33389564; PMCID: PMC8011939.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    137. Functional Neurologic and Surgical Outcomes Among Patients Undergoing Reoperation for Craniopharyngioma Recurrence. Neurosurgery. 2020 Dec 1; 67(Supplement_1). Aabedi AA, Young YJ, Phelps PR, Winkler WE, Theodosopoulos TP. .
      View in: Publisher Site   Mentions:
    138. Local Delivery of a Novel Combination Immunotherapy Increases T Cell Infiltration and Significantly Improves Survival in a Poorly Immunogenic Model of Glioblastoma. Neurosurgery. 2020 Dec 1; 67(Supplement_1). Haddad HA, Spatz SJ, Collins CS, Pereira PM, Gill GS, Montoya MM, Chuntova CP, Young YJ, Mummaneni MN, Kasahara KN, Aghi AM. .
      View in: Publisher Site   Mentions:
    139. Outcomes After Surgical Resection of Melanoma Brain Metastases in the Age of Checkpoint Inhibitor Treatment. Neurosurgery. 2020 Dec 1; 67(Supplement_1). Morshed MR, Morshed MR, Chung CJ, Sudhakar SV, Cummins CD, Young YJ, Daras DM, Aghi AM. .
      View in: Publisher Site   Mentions:
    140. Effects of Ventricular Entry During Glioblastoma Resection on Tumor Spread and Survival. Neurosurgery. 2020 Dec 1; 67(Supplement_1). Young YJ, Gogos GA, Pereira PM, Morshed MR, Barkovich BM, Li LJ, Hervey-Jumper HS, Berger BM. .
      View in: Publisher Site   Mentions:
    141. The Glioma-Network Interface: A Review of the Relationship Between Glioma Molecular Subtype and Intratumoral Function. Neurosurgery. 2020 11 16; 87(6):1078-1084. Young JS, Morshed RA, Gogos AJ, Amara D, Villanueva-Meyer JE, Berger MS, Hervey-Jumper SL. PMID: 34791466; PMCID: PMC7666965.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    142. The Glioma-Network Interface: A Review of the Relationship Between Glioma Molecular Subtype and Intratumoral Function. Neurosurgery. 2020 Nov 16; 87(6):1078-1084. Young YJ, Morshed MR, Gogos GA, Amara AD, Villanueva-Meyer VJ, Berger BM, Hervey-Jumper HS. .
      View in: Publisher Site   Mentions:
    143. EXTH-17. LOCAL DELIVERY OF CYTOKINES AND SYNTHETIC IMMUNOMODULATORS INCREASES T CELL INFILTRATION AND SIGNIFICANTLY IMPROVES SURVIVAL IN A POORLY IMMUNOGENIC MODEL OF GLIOBLASTOMA. Neuro-Oncology. 2020 Nov 9; 22(Supplement_2):ii90-ii90. Haddad HA, Spatz SJ, Collins CS, Pereira PM, Gill GS, Montoya MM, Chuntova CP, Young YJ, Mummaneni MN, Kasahara KN, Aghi AM. .
      View in: Publisher Site   Mentions:
    144. SURG-25. EFFECT OF VENTRICULAR ENTRY DURING GLIOBLASTOMA RESECTION ON PATIENT OUTCOMES. Neuro-Oncology. 2020 Nov 9; 22(Supplement_2):ii209-ii209. Young YJ, Gogos GA, Pereira PM, Morshed MR, Li LJ, Barkovich BM, Hervey-Jumper HS, Berger BM. .
      View in: Publisher Site   Mentions:
    145. SURG-07. DETECTION OF GLIOMA INFILTRATION AT THE TUMOR MARGIN USING QUANTITATIVE STIMULATED RAMAN SCATTERING MICROSCOPY. Neuro-Oncology. 2020 Nov 9; 22(Supplement_2):ii204-ii204. Pekmezci PM, Morshed MR, Chunduru CP, Pandian PB, Young YJ, Villanueva-Meyer VJ, Tihan TT, Sloan SE, Aghi AM, Molinaro MA, Berger BM, Hervey-Jumper HS. .
      View in: Publisher Site   Mentions:
    146. PATH-37. IDENTIFYING HIGH-RISK PATIENTS FOR WHO GRADE I MENINGIOMA RECURRENCE USING HISTOPATHOLOGICAL FEATURES AND THE MIB-1 INDEX. Neuro-Oncology. 2020 Nov 9; 22(Supplement_2):ii172-ii172. Haddad HA, Young YJ, Kanungo KI, Sudhir SS, Chen CJ, Raleigh RD, Magill MS, McDermott MM, Aghi AM. .
      View in: Publisher Site   Mentions:
    147. Functional Mapping for Glioma Surgery, Part 2: Intraoperative Mapping Tools. Neurosurg Clin N Am. 2021 Jan; 32(1):75-81. Morshed RA, Young JS, Lee AT, Hervey-Jumper SL. PMID: 33223028; PMCID: PMC7687734.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    148. Functional Mapping for Glioma Surgery, Part 2 Intraoperative Mapping Tools. Neurosurgery Clinics of North America. 2020 Nov 1. Morshed MR, Young YJ, Lee LA, Hervey-Jumper HS. .
      View in: Publisher Site   Mentions:
    149. Achieving efficacious immunotherapy for patients with glioblastoma. Expert Rev Anticancer Ther. 2020 11; 20(11):909-911. Young JS. PMID: 32852237.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    150. Surgical management of incidentally discovered low-grade gliomas. J Neurosurg. 2021 08 01; 135(2):480-487. Gogos AJ, Young JS, Pereira MP, Morshed RA, Potts MB, Hervey-Jumper SL, Berger MS. PMID: 33007758.
      View in: PubMed   Mentions: 8     Fields:    
    151. WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index. Front Oncol. 2020; 10:1522. Haddad AF, Young JS, Kanungo I, Sudhir S, Chen JS, Raleigh DR, Magill ST, McDermott MW, Aghi MK. PMID: 32983999; PMCID: PMC7483477.
      View in: PubMed   Mentions: 30  
    152. Intraoperative Stereotactic Frame Registration Using a Three-Dimensional Imaging System with and without Preoperative Computed Tomography for Image Fusion. Stereotact Funct Neurosurg. 2020; 98(5):313-318. Spatz JM, Conner AK, Young JS, Starr PA. PMID: 32818947.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    153. 12. OUTCOMES AFTER SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE AGE OF CHECKPOINT INHIBITOR TREATMENT. Neuro-Oncology Advances. 2020 Aug 4; 2(Supplement_2):ii1-ii2. Morshed MR, Chung CJ, Sudhakar SV, Cummins CD, Young YJ, Daras DM, Aghi AM. .
      View in: Publisher Site   Mentions:
    154. Triple motor mapping: transcranial, bipolar, and monopolar mapping for supratentorial glioma resection adjacent to motor pathways. J Neurosurg. 2021 06 01; 134(6):1728-1737. Gogos AJ, Young JS, Morshed RA, Avalos LN, Noss RS, Villanueva-Meyer JE, Hervey-Jumper SL, Berger MS. PMID: 32502996.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    155. Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution. Neurosurg Focus. 2020 06; 48(6):E13. Haddad AF, Young JS, Oh T, Pereira MP, Joshi RS, Pereira KM, Osorio RC, Donohue KC, Peeran Z, Sudhir S, Jain S, Beniwal A, Chopra AS, Sandhu NS, Theodosopoulos PV, Kunwar S, El-Sayed IH, Gurrola J, Blevins LS, Aghi MK. PMID: 32480370.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    156. Abstract A056: A study of race and socioeconomic status impacting therapeutic clinical trial enrollment in adult gliomas patients. Cancer Epidemiology Biomarkers & Prevention. 2020 Jun 1; 29(6_Supplement_2):a056-a056. Reihl RS, Morshed MR, Kakaizada KS, Zhang ZE, Young YJ, Clarke CJ, Butowski BN, Taylor TJ, Bush BN, Aghi AM, Berger BM, Chang CS, Hervey-Jumper HS. .
      View in: Publisher Site   Mentions:
    157. Molecular characteristics of diffuse lower grade gliomas: what neurosurgeons need to know. Acta Neurochir (Wien). 2020 08; 162(8):1929-1939. Young JS, Gogos AJ, Morshed RA, Hervey-Jumper SL, Berger MS. PMID: 32472378.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    158. A Safe Transitions Pathway for post-craniotomy neurological surgery patients: high-value care that bypasses the intensive care unit. J Neurosurg. 2021 05 01; 134(5):1386-1391. Young JS, Chan AK, Viner JA, Sankaran S, Chan AY, Imershein S, Meary-Miller A, Theodosopoulos PV, Jacques L, Aghi MK, Chang EF, Hervey-Jumper SL, Ward T, Gibson L, Ward MM, Sanftner P, Wong S, Amara D, Magill ST, Osorio JA, Venkatesh B, Gonzales R, Lau C, Boscardin C, Wang M, Berry K, McCullagh L, Reid M, Reels K, Nedkov S, Berger MS, McDermott MW. PMID: 32470928.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    159. The influence of race and socioeconomic status on therapeutic clinical trial screening and enrollment. J Neurooncol. 2020 May; 148(1):131-139. Morshed RA, Reihl SJ, Molinaro AM, Kakaizada S, Young JS, Schulte JD, Butowski N, Taylor J, Bush NA, Aghi MK, Berger MS, Chang S, Clarke J, Hervey-Jumper SL. PMID: 32350780.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    160. Awake glioma surgery: technical evolution and nuances. J Neurooncol. 2020 May; 147(3):515-524. Gogos AJ, Young JS, Morshed RA, Hervey-Jumper SL, Berger MS. PMID: 32270374.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    161. The impact of high functional connectivity network hub resection on language task performance in adult low- and high-grade glioma. J Neurosurg. 2021 03 01; 134(3):1102-1112. Lee AT, Faltermeier C, Morshed RA, Young JS, Kakaizada S, Valdivia C, Findlay AM, Tarapore PE, Nagarajan SS, Hervey-Jumper SL, Berger MS. PMID: 32244221; PMCID: PMC8011942.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    162. Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. JAMA Oncol. 2020 04 01; 6(4):495-503. Molinaro AM, Hervey-Jumper S, Morshed RA, Young J, Han SJ, Chunduru P, Zhang Y, Phillips JJ, Shai A, Lafontaine M, Crane J, Chandra A, Flanigan P, Jahangiri A, Cioffi G, Ostrom Q, Anderson JE, Badve C, Barnholtz-Sloan J, Sloan AE, Erickson BJ, Decker PA, Kosel ML, LaChance D, Eckel-Passow J, Jenkins R, Villanueva-Meyer J, Rice T, Wrensch M, Wiencke JK, Oberheim Bush NA, Taylor J, Butowski N, Prados M, Clarke J, Chang S, Chang E, Aghi M, Theodosopoulos P, McDermott M, Berger MS. PMID: 32027343; PMCID: PMC7042822.
      View in: PubMed   Mentions: 229     Fields:    Translation:HumansCells
    163. Mesolimbic dopamine D2 receptors and neural representations of subjective value. Sci Rep. 2019 12 27; 9(1):20229. Castrellon JJ, Young JS, Dang LC, Cowan RL, Zald DH, Samanez-Larkin GR. PMID: 31882947; PMCID: PMC6934551.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    164. QOLP-22. DRIVERS OF COST OF SURGERY IN NEWLY-DIAGNOSED GLIOBLASTOMA PATIENTS. Neuro-Oncology. 2019 Nov 11; 21(Supplement_6):vi202-vi202. Chandra CA, Young YJ, Dalle-Ore DC, Lau LD, Rick RJ, Wadhwa WH, McDermott MM, Berger BM, Aghi AM. .
      View in: Publisher Site   Mentions:
    165. RTHP-33. A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS ON SURVIVAL BASED ON TREATMENT PARADIGMS FOR PATIENTS WITH ANAPLASTIC OLIGODENDROGLIOMA. Neuro-Oncology. 2019 Nov 11; 21(Supplement_6):vi216-vi217. Young YJ, Zhang ZY, Molinaro MA, Taylor TJ, Clarke CJ, Prados PM, Chang CS, Berger BM, Butowski BN, Oberheim-Bush ON. .
      View in: Publisher Site   Mentions:
    166. SURG-20. IDENTIFICATION OF INFILTRATIVE CANCER CELLS AT THE GLIOMA RESECTION CAVITY MARGIN USING STIMULATED RAMAN SCATTERING MICROSCOPY. Neuro-Oncology. 2019 Nov 11; 21(Supplement_6):vi243-vi244. Morshed MR, Pekmezci PM, Young YJ, Aghi AM, McDermott MM, Theodosopoulos TP, Berger BM, Hervey-Jumper HS. .
      View in: Publisher Site   Mentions:
    167. SURG-14. DOES WAITING MATTER? HOW TIME FROM DIAGNOSTIC MRI TO SURGICAL RESECTION AFFECTS OUTCOMES IN NEWLY DIAGNOSED GLIOBLASTOMA. Neuro-Oncology. 2019 Nov 11; 21(Supplement_6):vi242-vi243. Young YJ, Muster MR, Chandra CA, Morshed MR, Aghi AM. .
      View in: Publisher Site   Mentions:
    168. ACTR-35. A STUDY OF RACE AND SOCIOECONOMIC STATUS IMPACTING THERAPEUTIC CLINICAL TRIAL ENROLLMENT IN ADULT GLIOMAS PATIENTS. Neuro-Oncology. 2019 Nov 11; 21(Supplement_6):vi21-vi21. Morshed MR, Reihl RS, Kakaizada KS, Zhang ZE, Young YJ, Clarke CJ, Butowski BN, Taylor TJ, Ann Oberheim-Bush AN, Aghi AM, Berger BM, Chang CS, Hervey-Jumper HS. .
      View in: Publisher Site   Mentions:
    169. Disruption of Frontal Aslant Tract Is Not Associated with Long-Term Postoperative Language Deficits. World Neurosurg. 2020 Jan; 133:192-195. Young JS, Morshed RA, Mansoori Z, Cha S, Berger MS. PMID: 31574328.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    170. Safe Transitions Pathway for Postcraniotomy Neurological Surgery Patients: High-Value Care That Bypasses the Intensive Care Unit. Neurosurgery. 2019 Sep 1; 66(Supplement_1). Young YJ, Chan CA, Viner VJ, Sankaran SS, Chan CA, Amara AD, Magill MS, Osorio OJ, Gibson GL, Sanftner SP, Ward WM, Ward WT, Wong WS, Aghi AM, Chang CE, Hervey-Jumper HS, Jacques JL, Theodosopoulos TP, Berger BM, McDermott MM. .
      View in: Publisher Site   Mentions:
    171. Management of Noncatastrophic Internal Carotid Artery Injury in Endoscopic Skull Base Surgery. Cureus. 2019 Aug 30; 11(8):e5537. Safaee M, Young JS, El-Sayed IH, Theodosopoulos PV. PMID: 31687310; PMCID: PMC6819080.
      View in: PubMed   Mentions: 2  
    172. Insurance type impacts the economic burden and survival of patients with newly diagnosed glioblastoma. J Neurosurg. 2020 07 01; 133(1):89-99. Chandra A, Young JS, Dalle Ore C, Dayani F, Lau D, Wadhwa H, Rick JW, Nguyen AT, McDermott MW, Berger MS, Aghi MK. PMID: 31226687.
      View in: PubMed   Mentions: 5     Fields:    
    173. Assessment of wakefulness during awake craniotomy to predict intraoperative language performance. J Neurosurg. 2020 06 01; 132(6):1930-1937. Aabedi AA, Ahn E, Kakaizada S, Valdivia C, Young JS, Hervey-Jumper H, Zhang E, Sagher O, Weissman DH, Brang D, Hervey-Jumper SL. PMID: 31151102; PMCID: PMC6885096.
      View in: PubMed   Mentions: 8     Fields:    
    174. The management of low-grade gliomas in adults. J Neurosurg Sci. 2019 Aug; 63(4):450-457. Morshed RA, Young JS, Hervey-Jumper SL, Berger MS. PMID: 30916536.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    175. Delirium Risk Factors and Associated Outcomes in a Neurosurgical Cohort: A Case-Control Study. World Neurosurg. 2019 Jun; 126:e930-e936. Morshed RA, Young JS, Safaee M, Sankaran S, Berger MS, McDermott MW, Hervey-Jumper SL. PMID: 30872201.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    176. The transcortical equatorial approach for gliomas of the mesial temporal lobe: techniques and functional outcomes. J Neurosurg. 2019 03 01; 130(3):822-830. Morshed RA, Young JS, Han SJ, Hervey-Jumper SL, Berger MS. PMID: 29676697.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    177. Immunotherapy for High-Grade Gliomas: A Clinical Update and Practical Considerations for Neurosurgeons. World Neurosurg. 2019 Apr; 124:397-409. Young JS, Dayani F, Morshed RA, Okada H, Aghi MK. PMID: 30677574; PMCID: PMC6642850.
      View in: PubMed   Mentions: 15     Fields:    
    178. Individual Differences in Dopamine Are Associated with Reward Discounting in Clinical Groups But Not in Healthy Adults. J Neurosci. 2019 01 09; 39(2):321-332. Castrellon JJ, Seaman KL, Crawford JL, Young JS, Smith CT, Dang LC, Hsu M, Cowan RL, Zald DH, Samanez-Larkin GR. PMID: 30446530; PMCID: PMC6325254.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    179. QOLP-02. INSURANCE STATUS IMPACTS THE ECONOMIC BURDEN AND SURVIVAL OF GLIOBLASTOMA PATIENTS WITH HEALTH INSURANCE. Neuro-Oncology. 2018 Nov 5; 20(suppl_6):vi214-vi214. Chandra CA, Young YJ, Ore OC, Lau LD, Rick RJ, Dayani DF, Nguyen NA, Garcia GJ, McDermott MM, Berger BM, Aghi AM. .
      View in: Publisher Site   Mentions:
    180. A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model. Neurotherapeutics. 2018 10; 15(4):1127-1138. Kim JW, Kane JR, Panek WK, Young JS, Rashidi A, Yu D, Kanojia D, Hasan T, Miska J, Gómez-Lim MA, Ulasov IV, Balyasnikova IV, Ahmed AU, Wainwright DA, Lesniak MS. PMID: 30027430; PMCID: PMC6277295.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    181. Perioperative outcomes following reoperation for recurrent insular gliomas. J Neurosurg. 2019 08 01; 131(2):467-473. Morshed RA, Young JS, Han SJ, Hervey-Jumper SL, Berger MS. PMID: 30239317.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    182. Using genomics to guide treatment for glioblastoma. Pharmacogenomics. 2018 10; 19(15):1217-1229. Young JS, Prados MD, Butowski N. PMID: 30203716.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    183. Gene Therapy and Virotherapy of Gliomas. Prog Neurol Surg. 2018; 32:112-123. Kim JW, Chang AL, Kane JR, Young JS, Qiao J, Lesniak MS. PMID: 29990979.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    184. Convection-Enhanced Delivery of Polymeric Nanoparticles Encapsulating Chemotherapy in Canines with Spontaneous Supratentorial Tumors. World Neurosurg. 2018 Sep; 117:e698-e704. Young JS, Bernal G, Polster SP, Nunez L, Larsen GF, Mansour N, Podell M, Yamini B. PMID: 29960096; PMCID: PMC6113082.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCTClinical Trials
    185. Sharpening the Surgeon's Knife: Value of Extent of Resection for Glioma in Molecular Age. World Neurosurg. 2018 09; 117:350-352. Morshed RA, Young JS, Hervey-Jumper SL. PMID: 29945007.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    186. Safety and outcomes of resection of butterfly glioblastoma. Neurosurg Focus. 2018 06; 44(6):E4. Dayani F, Young JS, Bonte A, Chang EF, Theodosopoulos P, McDermott MW, Berger MS, Aghi MK. PMID: 29852771.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    187. Relationship between tumor location, size, and WHO grade in meningioma. Neurosurg Focus. 2018 04; 44(4):E4. Magill ST, Young JS, Chae R, Aghi MK, Theodosopoulos PV, McDermott MW. PMID: 29606048.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    188. Chapter 15 Gene/Viral Treatment Approaches for Malignant Brain Cancer. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. 2018 Jan 1; 211-227. Kim KJ, Pituch PK, Xiao XA, Young YJ, Panek PW, Muroski MM, Rashidi RA, Kane KJ, Kanojia KD, Lesniak LM. .
      View in: Publisher Site   Mentions:
    189. Large-Scale Network Coupling with the Fusiform Cortex Facilitates Future Social Motivation. eNeuro. 2017 Sep-Oct; 4(5). Utevsky AV, Smith DV, Young JS, Huettel SA. PMID: 29034316; PMCID: PMC5635486.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    190. Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma. Oncotarget. 2017 Oct 24; 8(51):89391-89405. Panek WK, Kane JR, Young JS, Rashidi A, Kim JW, Kanojia D, Lesniak MS. PMID: 29179527; PMCID: PMC5687697.
      View in: PubMed   Mentions: 16     Fields:    
    191. Management of glioblastoma in elderly patients. J Neurol Sci. 2017 Sep 15; 380:250-255. Young JS, Chmura SJ, Wainwright DA, Yamini B, Peters KB, Lukas RV. PMID: 28870580; PMCID: PMC7328157.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    192. A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model. Mol Ther Oncolytics. 2017 Jun 16; 5:97-104. Kim JW, Miska J, Young JS, Rashidi A, Kane JR, Panek WK, Kanojia D, Han Y, Balyasnikova IV, Lesniak MS. PMID: 28573184; PMCID: PMC5443908.
      View in: PubMed   Mentions: 11  
    193. P08.46 Synergistic Therapeutic Efficacy via Immunomodulatory Platelet Rich Fibrin Patch (PRF-P) in Combination with Oncolytic Adenovirus for the Treatment of Glioma. Neuro-Oncology. 2017 Apr 1; 19(suppl_3):iii64-iii64. Panek PW, Kim KJ, Pituch PK, Kane KJ, Kanojia KD, Cordero CA, Miska MJ, Rashidi RA, Young YJ, Lesniak LM. .
      View in: Publisher Site   Mentions:
    194. 19 All Aboard Mesenchymal Stem/Stromal Cells as Cell Carriers for Virotherapy. Mesenchymal Stromal Cells as Tumor Stromal Modulators. 2017 Jan 1; 475-499. Kim KJ, Murphy MJ, Chang CA, Spencer SD, Kane KJ, Kanojia KD, Rashidi RA, Young YJ, Lesniak LM. .
      View in: Publisher Site   Mentions:
    195. The Impact of Traumatic Brain Injury on the Aging Brain. Curr Psychiatry Rep. 2016 09; 18(9):81. Young JS, Hobbs JG, Bailes JE. PMID: 27432348.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    196. Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters. J Transl Med. 2016 05 16; 14(1):134. Kim JW, Auffinger B, Spencer DA, Miska J, Chang AL, Kane JR, Young JS, Kanojia D, Qiao J, Mann JF, Zhang L, Wu M, Ahmed AU, Aboody KS, Strong TV, Hébert CD, Lesniak MS. PMID: 27184224; PMCID: PMC4868110.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    197. Sports-related concussions: diagnosis, complications, and current management strategies. Neurosurg Focus. 2016 Apr; 40(4):E5. Hobbs JG, Young JS, Bailes JE. PMID: 27032922.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    198. A novel single-chain antibody redirects adenovirus to IL13Rα2-expressing brain tumors. Sci Rep. 2015 Dec 14; 5:18133. Kim JW, Young JS, Solomaha E, Kanojia D, Lesniak MS, Balyasnikova IV. PMID: 26656559; PMCID: PMC4677343.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    199. ATPS-41DENDRITIC CELL BASED IMMUNOTHERAPY OF MALIGNANT GLIOMA VIA A NOVEL CD8a+ DC TARGETED ADENOVIRAL VECTOR. Neuro-Oncology. 2015 Nov 1; 17(suppl_5):v27-v27. Kim KJ, Kane KJ, Young YJ, Yu YD, Miska MJ, Chang CA, Rashidi RA, Ahmed AA, Balyasnikova BI, Lesniak LM. .
      View in: Publisher Site   Mentions:
    200. A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma. Hum Gene Ther. 2015 Sep; 26(9):635-46. Kim JW, Kane JR, Young JS, Chang AL, Kanojia D, Morshed RA, Miska J, Ahmed AU, Balyasnikova IV, Han Y, Zhang L, Curiel DT, Lesniak MS. PMID: 26058317; PMCID: PMC4575547.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    201. 22. A Novel Single-Chain Antibody for Selective Targeting of IL13Ra2-Expressing Brain Tumors. Molecular Therapy. 2015 May 1; 23:s10. Kim KJ, Young YJ, Lesniak LM, Balyasnikova BI. .
      View in: Publisher Site   Mentions:
    202. Neural stem cell-mediated delivery of oncolytic adenovirus. Curr Protoc Hum Genet. 2015 Apr 01; 85:13.11.1-13.11.9. Kim JW, Kane JR, Young JS, Chang AL, Kanojia D, Qian S, Spencer DA, Ahmed AU, Lesniak MS. PMID: 25827347; PMCID: PMC4403729.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    203. Synchrony between sensory and cognitive networks is associated with subclinical variation in autistic traits. Front Hum Neurosci. 2015; 9:146. Young JS, Smith DV, Coutlee CG, Huettel SA. PMID: 25852527; PMCID: PMC4369640.
      View in: PubMed   Mentions: 5  
    204. Sui generis: gene therapy and delivery systems for the treatment of glioblastoma. Neuro Oncol. 2015 Mar; 17 Suppl 2:ii24-ii36. Kane JR, Miska J, Young JS, Kanojia D, Kim JW, Lesniak MS. PMID: 25746089; PMCID: PMC4483038.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    205. Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy. Ther Deliv. 2015; 6(4):453-68. Spencer DA, Young JS, Kanojia D, Kim JW, Polster SP, Murphy JP, Lesniak MS. PMID: 25996044; PMCID: PMC4446703.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    206. ET-29AN OPTIMIZED ONCOLYTIC ADENOVIRUS FOR GLIOMA THERAPY: SPECIFIC TARGETING, EFFICIENT INFECTION, AND RESTRICTED REPLICATION IN GLIOMA. Neuro-Oncology. 2014 Nov 1; 16(suppl_5):v85-v86. Kim KJ, Kane KJ, Young YJ, Morshed MR, Chang CA, Ahmed AA, Balyasnikova BI, Lesniak LM. .
      View in: Publisher Site   Mentions:
    207. Caudate asymmetry is related to attentional impulsivity and an objective measure of ADHD-like attentional problems in healthy adults. Brain Struct Funct. 2016 Jan; 221(1):277-86. Dang LC, Samanez-Larkin GR, Young JS, Cowan RL, Kessler RM, Zald DH. PMID: 25269835; PMCID: PMC4433431.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    208. Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy. Expert Opin Drug Deliv. 2014 Nov; 11(11):1733-46. Young JS, Morshed RA, Kim JW, Balyasnikova IV, Ahmed AU, Lesniak MS. PMID: 25005767.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    209. Therapeutic cell carriers: a potential road to cure glioma. Expert Rev Neurother. 2014 Jun; 14(6):651-60. Young JS, Kim JW, Ahmed AU, Lesniak MS. PMID: 24852229.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    210. Radiation Dosimetry of (18)F-FPEB in Humans. J Nucl Med. 2014 Jul; 55(7):1119-21. Kessler RM, Seibyl J, Cowan RL, Zald D, Young JS, Ansari MS, Stabin MG. PMID: 24799618.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    Jacob's Networks
    Concepts (305)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (103)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.